Dr. Tewari on Trial With Cemiplimab in Recurrent or Metastatic Cervical Cancer
June 14th 2018Krishnansu Tewari, MD, associate professor, Division of Gynecologic Oncology, University of California, Irvine, discusses the GOG 3016/ENGOT-cx9 trial in patients with recurrent or metastatic cervical cancer.
Read More